Embolic Protection Devices Reduce the Risk of New Lesions During TAVR

Embolic Protection DevicesThe aim of this study was to investigate the efficacy and safety of cerebral protection devices during transcatheter aortic valve replacement (TAVR).

 

All randomized controlled trials investigating the efficacy of cerebral protection devices during TAVR are relatively small and lack statistical power for definitive conclusions.

 

That is the reason why this systematic review and meta-analysis was carried out. All trials using any type of cerebral protection device during TAVR were analyzed and included.

 

Primary imaging efficacy endpoints were total lesion volume and number of new ischemic lesions per magnetic resonance imaging scan. The primary clinical efficacy endpoint was any deterioration in the National Institutes of Health Stroke Scale (NIHSS) score at hospital discharge.

 

Four randomized trials with 252 total patients were included; in them, the use of cerebral protection devices reduced the total volume of new cerebral lesions (p = 0.002) as well as the number of new lesions (p = 0.03).

 

Cerebral protection device use was associated with a trend toward lower risk for deterioration in the NIHSS score at discharge (risk ratio [RR]: 0.55; 95% confidence interval [CI]: 0.27 to 1.09; p = 0.09).

 

The risk for stroke and all-cause mortality was lower in the cerebral protection group, although the difference was not significant.

 

Conclusion

The use of cerebral protection devices during transcatheter aortic valve replacement was associated with less amount and lower volume of new cerebral lesions.

 

Original title: Neurological Outcomes with Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement. A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Reference: Gennaro Giustino et al. J Am Coll Cardiol Intv. 2016;9(20):2124-2133.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...